Background Autologous hematopoietic stem cell transplantation has been used since 1996
for the treatment of severe autoimmune diseases refractory to approved therapies. We …

This ongoing multicentre prospective phase I/II trial enrolled 74 consecutive patients from 22
centres worldwide with severe autoimmune disease, 35 with rheumatological disorders, 31 …

Abstract Since Morton and Siegel's epochal experiments 30 years ago animal models have
been successfully utilized both for transfer and resolution of autoimmune diseases (AID) …

Since 1996, approximately 1,000 patients have received an autologous hematopoietic stem
cell transplant (HSCT) as treatment for a severe autoimmune disease (AD). The European …

Experimental data and early phase I/II studies suggest that high-dose chemotherapy
followed by autologous hematopoietic stem cell transplantation (HSCT) can arrest …

Around 700 patients have received an autologous haematopoietic stem cell transplant
(HSCT) as treatment for a severe autoimmune disease (AD). The majority of these have …

Haematopoietic stem cell transplantation was proposed as a treatment strategy just over 60
years ago. Owing to great advances in the field, haematopoietic stem cell transplantation …

To determine the role of allogeneic, autologous and syngeneic hemopoietic stem cell
transplantation (SCTx) as a treatment for severe autoimmune disease (AID) we performed a …

Allogeneic hematopoietic SCT (HSCT) has been used as treatment for single patients with
autoimmune diseases (AD). To summarise currently available information, we analyzed all …

Autologous haematopoietic stem cell transplantation (aHSCT) is commonly used for the
treatment of haematological cancers, but is increasingly used in the treatment of patients …